Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

By C. Ripoll, R. Groszmann, G. Garcia‐Tsao, N. Grace, Andrew K. Burroughs, R. Planas, À. Escorsell, J. García‐Pagán, R. Makuch, D. Patch and 2 more. Gastroenterology, 2007

1,085 citations recorded by the source corpus.

Subfields: Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/c9c5e1760def06cbfba6309620f7fb26e2239d65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. S. Friedman
2. M. Pinzani
3. P. Ginés
4. Christian Trautwein
5. J. Bosch
6. M. Bernardi
7. P. Angeli
8. W. Laleman

In Surgery

1. S. Friedman
2. J. Bosch
3. P. Ginés
4. Laurent Castéra

Citations in the corpus

• Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. (2021, background): “The presence of clinically significant portal hypertension (CSPH, HVPG ≥10 mmHg), has been shown to be the strongest prognostic determinant in patients with cACLD [93].”
• Evolving challenges in hepatic fibrosis (2010, background): “In fact, the test is remarkably accurate in determining which patients with cirrhosis are at risk for decompensatio”
• The clinical use of HVPG measurements in chronic liver disease (2009, background): “whereas clinically significant portal hypertension is diagnosed when HVPG is ≥10 mmHg, at which point clinical manifestations of portal hypertensive syndrome, such as varices, bleeding, gastropathy, and ascites, might appear”
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “Portal hypertension also contributes [30] by acting as a compartmentalising factor of the expanded extracellular fluid volume.”
• Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases (2017, background): “It is important to recognize that although PH and its direct consequences (varices) form the bases of staging in CC, liver insufficiency, even at this stage, plays an important role, given that serum albumin and the Model for End-Stage Liver Disease (MELD) score are also independent predictors of de”
• Hepatic fibrosis: Concept to treatment. (2015, background): “These endpoints could include hepatic venous pressure gradient [79], which correlates strongly with clinical outcomes, as well as MELD or Child-Pugh scores.”
• Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient (2009, background): “The long follow-up period (to the last biopsy) with a median of 48 (9-168) months and the spread of severity of the recurrent HCV disease after liver transplantation (38 of 115 patients developed cirrhosis, that is, stage 5/6) made this a suitable cohort of patients to assess CPA in relation to hist”
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) (2009, background): “Acute variceal bleeding has been included as one of the events to define hepatic decompensation in the natural history of cirrhosis [27].”
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 (2009, neutral): “Acute variceal bleeding has been included as one of the events to define hepatic decompensation in the natural history of cirrhosis [27].”